EUVIMEDEUVIMED entdecken
Fall-Kontroll-StudieOpen Access · CC BY 4.0

Glucocorticoid use and candidemia: results from a nationwide case-control study

Cæcilie Leding, Alessandra Meddis, Jon Gitz Holler, Karen Marie Thyssen Astvad, Thomas Benfield

Clinical Microbiology and Infection · 2026

DOI: 10.1016/j.cmi.2026.05.033 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Clinical Microbiology and Infection, 2026. Verfasst von Cæcilie Leding und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark. Electronic address: Caecilie.leding@regio…. Hauptthemen laut MEDLINE: Glucocorticoids, Candidemia. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Glucocorticoids are widely used for acute and chronic diseases. Although their association with increased infection risk is well-established, population-level data on glucocorticoid use and candidemia are limited. We investigated the association between oral glucocorticoid exposure and candidemia in a population-based setting over 14 years, with attention to variation by dose, Candida species and underlying disease. METHODS: We conducted a nationwide, registry-based case-control study (2010-2024) including all Danish adults with a first-time Candida bloodstream infection (cases), matched to ten population controls. Glucocorticoid use was defined as redemption of an oral glucocorticoid prescription within 90 days before the index date, categorized by 90-day prednisolone-equivalent cumulative dose. Adjusted odds ratios (aORs) with 95% CIs were estimated using conditional logistic regression. Subgroup analyses evaluated variation by species and underlying conditions. RESULTS: We included 6179 cases and 61 790 controls. Glucocorticoid use was associated with higher odds of candidemia overall (aOR: 2.17, 95% CI: 1.92-2.45), and across major species groups including C. albicans (aOR: 2.22, 95% CI: 1.86-2.65), C. glabrata (aOR: 2.08, 95% CI: 1.70-2.55), C. tropicalis (aOR: 2.22, 95% CI: 1.22-4.04), C. krusei (aOR: 2.38, 95% CI: 1.26-4.48), C. parapsilosis (aOR: 2.80, 95% CI: 1.62-4.85), but not C. dubliniensis (aOR: 1.45, 95% CI: 0.68-3.09). The odds increased with higher cumulative doses ( 1500 mg; aOR: 5.23, 95% CI: 4.01-6.83, compared to nonusers). The highest odds were observed among patients with inflammatory bowel disease (aOR: 4.62, 95% CI: 2.21-9.43), followed by rheumatic disease (aOR: 3.15, 95% CI: 2.28-4.35), and chronic pulmonary disease (aOR: 2.07, 95% CI: 1.67-2.56). CONCLUSION: Glucocorticoid use is associated with increased candidemia odds with a clear dose-dependent relationship, consistent across common Candida species, and most pronounced in inflammatory bowel disease, rheumatic disease, and chronic pulmonary disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucocorticoidsCandidemiaHumansCase-Control StudiesDenmarkFemaleMiddle AgedCandidaAgedMaleAdultRisk FactorsRegistries

Stichwörter der Autor:innen

CorticosteroidsImmunosuppressionInvasive candidiasisInvasive fungal infectionSystemic glucocorticoids

Substanzen

Glucocorticoids

Autor:innen und Institutionen

  • Department of Infectious Diseases, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark. Electronic address: Caecilie.leding@regionh.dk.
  • Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
  • Department of Pulmonary and Infectious Diseases, Copenhagen University Hospital - North Zealand, Hillerød, Denmark.
  • Unit of Mycology, Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
  • Department of Infectious Diseases, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen,…

Zitieren

APA

Leding, C., Meddis, A., Holler, J. G., Astvad, K. M. T., & Benfield, T. (2026). Glucocorticoid use and candidemia: results from a nationwide case-control study. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2026.05.033

Vancouver

Leding C, Meddis A, Holler JG, Astvad KMT, Benfield T. Glucocorticoid use and candidemia: results from a nationwide case-control study. Clinical Microbiology and Infection. 2026. doi:10.1016/j.cmi.2026.05.033

BibTeX
@article{Leding2026,
  author = {Leding, Cæcilie and Meddis, Alessandra and Holler, Jon Gitz and Astvad, Karen Marie Thyssen and Benfield, Thomas},
  title = {Glucocorticoid use and candidemia: results from a nationwide case-control study},
  journal = {Clinical Microbiology and Infection},
  year = {2026},
  doi = {10.1016/j.cmi.2026.05.033}
}
Kostenlos starten →